Skip to content
Screener

Veradermics MANE Balance Sheet Statement

Q1 '26Q4 '25Q1 '25Q4 '24Q3 '24
$168.41M+419%$21.77M-59.0%$32.44M—$53.08M———
$222.39M—$120.1M———$0———
$397.07M—$152.49M+175%——$55.54M———
$21K—$22K———$0———
$287K—$125K———$0———
$397.36M—$152.62M+175%——$55.54M———
$1.07M+256%$2.13M-5.4%-$686K-525%$2.25M—$161.5K—
$6.72M—$9.15M+94.0%——$4.72M———
$6.72M—$9.16M+94.1%——$4.72M———
——$1K0.0%——$1K———
-$150.65M—-$123.42M-151%——-$49.23M———
$390.64M+744%-$121.01M-150%-$60.67M—-$48.48M-118%——
$397.36M—$152.62M+175%——$55.54M———

FAQ

What are Veradermics's total assets?
Veradermics (MANE) holds $397.4M in total assets.
How much cash does Veradermics have?
Veradermics holds $168.4M in cash and equivalents.
Can Veradermics cover its short-term obligations?
Its current ratio is 59.12 — current assets exceed current liabilities.
Where does Veradermics's balance sheet data come from?
Every line is extracted from Veradermics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.